Open Access
How to Use an Article About Therapy or Prevention
Gordon H. Guyatt,David L. Sackett,Deborah J. Cook +2 more
- 01 Jan 1995
484
TL;DR: A 19 year-old woman who has had systemic lupus erythematosus diagnosed on the basis of a characteristic skin rash, arthritis, and renal disease is seeing an internal medicine resident in a rheumatology rotation.
read more
Abstract: You are working as an internal medicine resident in a rheumatology rotation and are seeing a 19 year-old woman who has had systemic lupus erythematosus diagnosed on the basis of a characteristic skin rash, arthritis, and renal disease. A renal biopsy has shown diffuse proliferative nephritis. A year ago, her creatinine was 140 micromoles/litre, six months ago 180, and in a blood sample taken a week before this clinic visit, 220. Over the last year she has been taking prednisone, and over the last six months, cyclophosphamide, both in appropriate doses.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
An evidence-based approach to selected joint therapies in horses.
TL;DR: This article concentrates on injectable polysulfated glycosaminoglycan, injectable hyaluronan, and the common oral "nutraceuticals".
17
Practical approach to grading evidence for formulary recommendations
Nicole T. Ansani,Bethany A. Fedutes-Henderson,Susan J. Skledar,Robert A. Branch,Carl A. Sirio,Thomas Smitherman,Robert J. Weber +6 more
TL;DR: One important function of a pharmacy and therapeutics committee is to provide judicious formulary review, with recommendations for management and selection of optimal treatment agents, and advice and strategies in therapeutic algorithms.
17
Interpreting research on clinical prediction rules for physiotherapy treatments.
TL;DR: In this article, methodological issues may affect the information that can be taken from a study on a physiotherapy treatment CPR, and they hope this discussion will help clinicians feel more comfortable about interpreting this type of research.
17
Endpoint Selection and Relative (Versus Absolute) Risk Reporting in Published Medication Trials
Michael Hochman,Danny McCormick +1 more
TL;DR: The use of surrogate and composite endpoints, endpoints involving disease-specific mortality, and relative risk reporting in clinical trials is common and articles should highlight the limitations of these endpoints and should report results in absolute terms.
Meta-analyses of placebo-controlled trials of acamprosate for the treatment of alcohol dependence: impact of the combined pharmacotherapies and behavior interventions study.
TL;DR: It is confirmed that acamprosate and naltrexone are both effective agents for the treatment of patients with alcohol dependence and clinicians should use both these sources of information as their foundation for selecting optimal therapy for patients withalcohol dependence.
16
References
•Book
Clinical Epidemiology: A Basic Science for Clinical Medicine
David L. Sackett
- 01 Jan 1985
TL;DR: Clinical Epidemiology is a book dedicated to H.L. Mencken, Kurt Vonnegut, Jr., Douglas Adams, and the Emperor's New Clothes and Physicians and others who wish to recognize key clinical epidemiologic features of the diagnosis and management of patients will benefit from reading.
4K
•Book
Users' Guides to the Medical Literature
Gordon H. Guyatt,Drummond Rennie +1 more
- 01 Jan 2001
TL;DR: Without a way of critically appraising the information they receive, clinicians are relatively helpless in deciding what new information to learn and decide how to modify their practice.
3.4K
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Echt Ds,Philip R. Liebson,Mitchell Lb,Robert W. Peters,Obias-Manno D,Barker Ah,Arensberg D,Baker A,Lawrence S. Friedman,Greene Hl +9 more
TL;DR: There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
3.1K
An assessment of clinically useful measures of the consequences of treatment.
TL;DR: The goal is to provide a clear picture of the individual components of the immune system and provide a strategy for individualized treatment of these components according to their Kesslerian importance.
1.6K
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
Roger C. Bone,Charles J. Fisher,Terry P. Clemmer,Gus J. Slotman,Craig A. Metz,Robert A. Balk +5 more
TL;DR: It is concluded that the use of high-dose corticosteroids provides no benefit in the treatment of severe sepsis and septic shock.
1.4K
Related Papers (5)
Gordon H. Guyatt,Drummond Rennie +1 more
- 01 Jan 2001
Gordon H. Guyatt,David L. Sackett,Deborah J. Cook,Gordon Guyatt,Eric B Bass,Patrick Brill-Edwards,George P. Browman,Deborah Cook,Michael E. Farkouh,Hertzel C. Gerstein,Brian Haynes,Robert Hayward,Anne Holbrook,Roman Jaeschke,Elizabeth F. Juniper,Andreas Laupacis,Hui Lee,Mitchell Levine,Virginia Moyer,Jim Nishikawa,Andrew D Oxman,Ameen Patel,John Philbrick,W. Scott Richardson,Stephane Sauve,David L. Sackett,Jack Sinclair,K. S. Trout,Peter Tugwell,Sean Tunis,Stephen D. Walter,John W Williams,Mark Wilson +32 more
David L. Sackett
- 14 Mar 2000
Roman Jaeschke,Gordon H. Guyatt,David L. Sackett,Eric Bass,Patrick Brill-Edwards,George P. Browman,Deborah J. Cook,Michael E. Farkouh,Hertzel C. Gerstein,Brian Haynes,Robert Hayward,Anne Holbrook,Elizabeth F. Juniper,Hui Lee,Mitchell Levine,Virginia Moyer,Jim Nishikawa,Andrew D Oxman,Ameen Patel,John Philbrick,W. Scott Richardson,Stephane Sauve,David L. Sackett,Jack Sinclair,K. S. Trout,Peter Tugwell,Sean Tunis,Stephen D. Walter,Mark C. Wilson +28 more